Acadia Pharmaceuticals Inc
NASDAQ:ACAD 3:59:58 PM EDT
Other Pre-Announcement
Acadia Pharmaceuticals Reports First Quarter 2022 Financial Results
Published: 05/04/2022 21:32 GMT
Acadia Pharmaceuticals Inc (ACAD) - Acadia Pharmaceuticals Reports First Quarter 2022 Financial Results.
Q1 Sales Rose 8 Percent to $115.5 Million.
Q1 Loss per Share $0.70.
Sees FY Sales $510 Million to $560 Million.
Q1 Earnings per Share View $-0.60, Revenue View $121.9 Million -- Refinitiv Ibes Data (analyst estimates).
Is Reiterating Its Previously Provided Guidance Ranges.
Q1 Sales Rose 8 Percent to $115.5 Million.
Q1 Loss per Share $0.70.
Sees FY Sales $510 Million to $560 Million.
Q1 Earnings per Share View $-0.60, Revenue View $121.9 Million -- Refinitiv Ibes Data (analyst estimates).
Is Reiterating Its Previously Provided Guidance Ranges.